BRAFTOVI: payments to doctors
Payments that named BRAFTOVI as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $3.7M
- Providers
- 9,234
- Transactions
- 39,722
- Average per transaction
- $93
The per-transaction average — $93 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 9,234 providers the average total is $398, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Array Biopharma Inc | $1,812,370 | 49.3% |
| Pfizer | $1,423,337 | 38.7% |
| Array Biopharma Inc. | $429,627 | 11.7% |
| Whitehall International Inc | $6,244 | 0.2% |
| Pfizer Chile S.A. | $4,311 | 0.1% |
| PBG Puerto RICO LLC | $213 | 0.0% |
| Medivation Services LLC | $130 | 0.0% |